Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,442 across all filing types
Latest filing 2020-11-16 Capital/Financing Update
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Imugene Limited. It details the number and type of securities to be issued, the issue price, underwriting arrangements, and compliance with ASX listing rules. There are no financial statements or detailed financial performance data included, and the document is focused on informing about the capital raising activity. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other filing types.
2020-11-16 English
Appendix 2A 15 pages 387.8KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The document is a formal announcement related to the listing and quotation of new securities, not a financial report, earnings release, or management discussion. It is a regulatory announcement about capital market activity, specifically the quotation of securities. This fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is not a brief notice or a report publication announcement. Therefore, the classification is CAP with high confidence.
2020-11-16 English
Appendix 2A 15 pages 388.1KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes details about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The document is a formal announcement related to the listing or quotation of new securities rather than a financial report or earnings release. It is not a report itself but an application/announcement for quotation of securities, which aligns with capital or financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the securities issuance and quotation application, confirming it is not a mere announcement of a report or a certification.
2020-11-09 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Imugene Limited. It details the number of securities to be issued, the issue price, underwriting arrangements, and compliance with ASX listing rules. There is no financial statement or comprehensive financial report included, only information about the capital raising activity. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2020-11-09 English
Becoming a substantial holder 2 pages 6.0MB
Regulatory Filings
2020-11-03 English
Proposed issue of Securities - IMU 6 pages 30.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Imugene Limited. It details the number and type of securities to be issued, the issue price, underwriting arrangements, and compliance with ASX listing rules. There is no financial performance data, management discussion, or audit information. The content focuses on capital raising activities and issuance of new shares. Therefore, this fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief notice or a simple report publication announcement but a substantive announcement about a financing event.
2020-11-03 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.